Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Urinary Incontinence: early-phase trial registry
18 of 50 indexed Urinary Incontinence trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #277 of 28,707 conditions by registered trial count.
50 US clinical trials · 18 currently recruiting · #277 of 28,707 conditions by registered trial count
Urinary Incontinence: 50 US clinical trials tracked, 18 recruiting.
Urinary Incontinence is the subject of 50 registered US clinical trials on ClinicalTrials.gov, 18 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most active sponsor is BTL Industries, running 3 of these trials.
Enrollment posture brief
Registry condition urinary-incontinence
OPEN 18 | RECR 36% | LATE 5 | EARLY 11 | RANK #277 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Lymphocytic Leukemia (36% recruiting · 25 trials)
Urinary Incontinence lists 18 open slots (36% of 50 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Urinary Incontinence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Urinary Incontinence is recruiting below its size-band peers.
18 of 50 indexed trials (36%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Urinary Incontinence trials is spread across many organizations.
BTL Industries accounts for 3 of 50 trials (6%). 39 distinct sponsors appear on at least one study for this condition label.
-
Typical Urinary Incontinence enrolment sits around 100 participants.
Median target enrolment is 100 among the 49 trials that report a genuine target (sentinel values excluded). 24 of those (49%) plan for fewer than 100 participants.
-
Urinary Incontinence research is mostly interventional.
43 interventional and 7 observational studies make up this index (86% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
50 total, page 1 of 1
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
NICHD Pelvic Floor Disorders Network
NCT06480227
TReating Incontinence for Underlying Mental and Physical Health
University of California, San Francisco
NCT05362292
Training for Urinary Leakage Improvement After Pregnancy
NICHD Pelvic Floor Disorders Network
NCT06411158
NXT Post-Market Clinical Follow-up
Laborie Medical Technologies
NCT06336304
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
Uromedica
NCT04248283
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
University of Rochester
NCT06369922
Effect of Group Preoperative Pelvic Floor Training for HoLEP
University of California, San Francisco
NCT05719220
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Northwestern University
NCT05878951
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
Augusta University
NCT05771597
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
BTL Industries
NCT07413705
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women
BTL Industries
NCT07413692
Improving Overactive Bladder Treatment Access and Adherence
Stanford University
NCT06094543
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
The University of Texas Medical Branch, Galveston
NCT04565925
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
Urological Research Network
NCT05698576
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
University of Wisconsin, Madison
NCT06840899
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
VA Office of Research and Development
NCT05141487
Muscle Fiber Fragment Treatment for Urinary Incontinence
Wake Forest University
NCT01953263
rTMS in Overactive Bladder
The Methodist Hospital Research Institute
NCT06198439
Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans
University of Alabama at Birmingham
NCT05438849
A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence
University of California, San Diego
NCT05534412
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
Brigham and Women's Hospital
NCT03522961
Use of Artificial Intelligence by Urogynecologic Patients
Hartford Hospital
NCT06481436
Physical Therapy for Men Undergoing Prostatectomy
Indiana University
NCT02558946
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
The University of Texas Medical Branch, Galveston
NCT05880862
WI-INTUIT: Bridging Community Based Continence Promotion and Primary Care
Medical College of Wisconsin
NCT05664451
Clinical Study of External Electrical Stimulation for Male Incontinence
Elidah
NCT06620419
Use of Sildenafil for Treatment of Urinary Incontinence
The University of Texas Medical Branch, Galveston
NCT02983461
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
Pfizer's Upjohn has merged with Mylan to form Viatris
NCT00147654
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Duramed Research
NCT00196404
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Ananias Diokno
NCT01479816
Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence
Carelon Research
NCT00064662
Translating Unique Learning for Incontinence Prevention
University of Michigan
NCT01599715
Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women
University of Michigan
NCT00763984
Improving Care for Women With Urinary Incontinence (EMPOWER)
University Hospitals Cleveland Medical Center
NCT05515198
A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.
Astellas Pharma
NCT00333112
Urge Incontinence Bladder Overactivity Study
Eli Lilly and Company
NCT00475696
Improving Women's Health by Using an Electronic Pelvic Floor Questionnaire
University of Wisconsin, Madison
NCT00880880
An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence
Boston Scientific Corporation
NCT00080470
Pelvic Floor Disorder Assessment of Knowledge and Symptoms: an Educational Model in Spanish-Speaking Women
Johns Hopkins University
NCT04829721
Voiding Assessment Based on Minimum Spontaneous Void of 150 mL Compared to Retrograde Fill Method After Female Pelvic Floor Reconstructive Surgery
Yale University
NCT03539107
What is the Impact of the Presence of a Support Person on Informed Consent
Hartford Hospital
NCT03966469
The Urinary Incontinence Treatment Study
Wake Forest University Health Sciences
NCT03057834
TVT-SECUR as an Office-based Procedure
Michigan Institution of Women's Health PC
NCT01137539
Efficacy of rPMS for Improvement of Urinary Incontinence and Female Sexual Function
BTL Industries
NCT03942484
Physical Exercise and Bladder Training Program for Urinary Incontinence
University of Pennsylvania
NCT03869918
Lessening Incontinence by Learning Yoga
University of California, San Francisco
NCT01672190
Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT)
Women and Infants Hospital of Rhode Island
NCT01288703
Muscle Progenitor Cell Therapy for Urinary Incontinence
Wake Forest University
NCT01953315
Incontinence Management System ICU Field Evaluation
Hill-Rom
NCT03628833
Mindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)
University of Utah
NCT01470560
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 7 |
| Phase 3 | 2 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Urinary Incontinence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Urinary Incontinence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Urinary Incontinence page
50 registered trials, 18 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 18 Urinary Incontinence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- BTL Industries sponsors the most Urinary Incontinence trials on record, review their full trial history before evaluating a specific study. See BTL Industries's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Urinary Incontinence condition card totals 50 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.